Open AccessTBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
Unc LibrariesK. Componeschi +202021
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support